Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
The Lancet. Rheumatology
|
January 30, 2024
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Philip J Mease, Philip S Helliwell, Dafna D Gladman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Oncologist use and perception of large panel next-generation tumor sequencing
A M Schram, D Reales, J Galle, et al.
RMD Open
|
February 11, 2021
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced
Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Cancer Research
|
September 27, 2017
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4<sup>+</sup> TILs in the Presence of PD-L1<sup>+</sup> TAMs
Austin K Mattox, Jina Lee, William H Westra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2024
ESMO Recommendations on clinical reporting of genomic test results for solid cancers
J van de Haar, P Roepman, F Andre, et al.
BMJ Open
|
December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
Rebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
C B Westphalen, L Boscolo Bielo, P Aftimos, et al.
Seminars in Arthritis and Rheumatism
|
February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
Rachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
The Lancet. Rheumatology
|
January 30, 2024
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Philip J Mease, Philip S Helliwell, Dafna D Gladman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Oncologist use and perception of large panel next-generation tumor sequencing
A M Schram, D Reales, J Galle, et al.
RMD Open
|
February 11, 2021
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced
Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Cancer Research
|
September 27, 2017
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4<sup>+</sup> TILs in the Presence of PD-L1<sup>+</sup> TAMs
Austin K Mattox, Jina Lee, William H Westra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2024
ESMO Recommendations on clinical reporting of genomic test results for solid cancers
J van de Haar, P Roepman, F Andre, et al.
BMJ Open
|
December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
Rebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
C B Westphalen, L Boscolo Bielo, P Aftimos, et al.
Seminars in Arthritis and Rheumatism
|
February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
Rachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.
Page
of 10